Treatment modalities and outcomes in pediatric Cushing's disease - report of three cases and literature review.
Viviana MarquesSofia FerreiraCarla CostaCíntia Castro-CorreiaRita Santos-SilvaPublished in: Journal of pediatric endocrinology & metabolism : JPEM (2024)
TSS remains the first-line treatment yet challenging due to microadenomas and technical complexities. Medical therapy with agents like metyrapone or ketoconazole, pituitary radiotherapy, or bilateral adrenalectomy are, usually, second-line interventions, unless there is a contraindication to surgery. Our findings support the finding that a shorter hypothalamic-pituitary-adrenal axis recovery time increases the risk of recurrence of CD. Our cases illustrate the intricate management and variable outcomes of pediatric CD, underscoring the importance of multidisciplinary care and continuous surveillance.
Keyphrases
- healthcare
- case report
- minimally invasive
- public health
- quality improvement
- early stage
- palliative care
- physical activity
- coronary artery bypass
- radiation therapy
- coronary artery disease
- skeletal muscle
- locally advanced
- squamous cell carcinoma
- pain management
- mesenchymal stem cells
- metabolic syndrome
- cell therapy
- combination therapy
- surgical site infection
- free survival